Document Detail

A Minimal Model of Tumor Growth Inhibition.
MedLine Citation:
PMID:  19272954     Owner:  NLM     Status:  Publisher    
The preclinical development of antitumor drugs greatly benefits from the availability of models capable of predicting tumor growth as a function of the drug administration schedule. For being of practical use such models should be simple enough to be identifiable from standard experiments conducted on animals. In the present paper, a stochastic model is derived from a set of minimal assumptions formulated at cellular level. Tumor cells are divided in two groups: proliferating and nonproliferating. The probability that a proliferating cell generates a new cell is a function of the tumor weight. The probability that a proliferating cell becomes nonproliferating is a function of the plasma drug concentration. The time-to-death of a nonproliferating cell is a random variable whose distribution reflects the nondeterministic delay between drug action and cell death. The evolution of the expected value of tumor weight obeys two differential equations (an ordinary and a partial differential one), whereas the variance is negligible. Therefore, the tumor growth dynamics can be well approximated by the deterministic evolution of its expected value. The Tumor Growth Inhibition (TGI) model, which is a lumped parameter model that in the last few years has been successfully applied to several antitumor drugs, is shown to be a special case of the minimal model presented here.
P Magni; M Germani; G De Nicolao; G Bianchini; M Simeoni; I Poggesi; M Rocchetti
Related Documents :
3607784 - Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminop...
21242834 - Ependymoma and choroid plexus papilloma as synchronous multiple neuroepithelial tumors ...
11445854 - Apoptosis and thymidylate synthase inductions by 5-fluorouracil in gastric cancer cells...
24173314 - Mouse to human blood-based cancer biomarker discovery strategies.
2992764 - Caffeine and other phosphodiesterase inhibitors are potent inhibitors of the promotiona...
10651414 - Dendritic cells in selected head and neck tumors.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2008-6-10
Journal Detail:
Title:  IEEE transactions on bio-medical engineering     Volume:  -     ISSN:  1558-2531     ISO Abbreviation:  IEEE Trans Biomed Eng     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2009-3-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0012737     Medline TA:  IEEE Trans Biomed Eng     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Microelectrode Array (MEA) Platform for Targeted Neuronal Transfection and Recording.
Next Document:  An ECG Signals Compression Method and its Validation Using NN's.